Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-040824
Filing Date
2018-06-18
Accepted
2018-06-18 16:56:10
Documents
2
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 15433
2 EX-24 ex-24.htm EX-24 8316
  Complete submission text file 0001104659-18-040824.txt   25078
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMPHASTAR PHARMACEUTICALS INC 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address
Liawatidewi Yakob (Reporting) CIK: 0001743927 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36509 | Film No.: 18905218